Home›People›Reetika Bhardwaj
Reetika Bhardwaj

Reetika Bhardwaj

Director at MindImmune Therapeutics.

Director
Updated Nov 11, 2026·Latest SEC filing Mar 5, 2026·Suggest an edit

About Reetika Bhardwaj

Reetika Bhardwaj is a director at MindImmune Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Reetika Bhardwaj in the role, so the role may have started earlier or lasted longer.

MindImmune Therapeutics, Inc.
Director
2025 – 2026 · Kingston, RI
Develops immune-targeting drugs for people with Alzheimer's and other neurodegenerative diseases.

Key Colleagues at Startups

The people Reetika Bhardwaj works with at each company, as listed on that company's latest Form D.

MindImmune Therapeutics, Inc. · Form D/A, Mar 5, 2026
Bradley Margus
Bradley Margus
Board Chair
Isaac Stoner
Isaac Stoner
CEO and director

Sources

  1. SECMindImmune Therapeutics, Inc. Form D/A, filed Mar 5, 2026